Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

Agilis NxT

STEERABLE INTRODUCER

Clinical Evidence

Choose the Gold Standard

As evidenced in more than one million procedures*, for a growing number of physicians, Agilis™ NxT Steerable Introducer is the introducer of choice when guiding ablation catheters to treat arrhythmias. Tailor to your patient’s anatomy with a large variety of sizes & curves that maintain their shape.

Curve sizes for the Agilis NxT Steerable Introducer

 

Confident steering and stable positioning with exceptional maneuverability

Enhanced catheter stability enables control of tip movements within millimeters along the intended ablation line1

Access hard-to-reach areas with precise maneuverability and auto-lock steering, such as the right inferior and left anterior pulmonary veins1

 

Enhanced procedural efficiency with exceptional contact force

60%

 

 

Greater catheter-tissue contact force, which may support more durable lesion formation2

 

 

Higher left atrial wall contact, and more efficient energy delivery, especially critical for thicker left atrial musculature1

 

Reliable, Complete Lesion Creation Through Outstanding Agility and Stability

Increase of 43 Percent Increase of 43 Percent

 

Greater freedom from arrhythmia at 6 months (76.0% vs 53.0%)3 and 18% greater at 12 months (74.0% vs 62.7%)4

Greater than 5 times Greater than 5 times

 

Complete PVI isolation (left- and right-sided veins) (43 pts vs 8 pts)1

Decrease of 74% Decrease of 74%

 

Fewer re-do ablations (6 pts vs 23 pts)1 and 17% fewer acute PV reconnections (50% vs 60%)5

BOLD SOLUTIONS
TO CHALLENGE AFIB

Learn More
Manuals & Resources

Manuals & Resources

Cardiovascular Products

Cardiovascular Products

Customer Service

Customer Service

*Based on sales through Dec 31, 2020

References

  1. Piorkowski C, et al. (2008). Steerable sheath catheter navigation for ablation of atrial fibrillation: A case-control study. Pacing and Clinical Electrophysiology, 31(7), 863–873.
  2. Cuoco F, et al. (2014). Steerable sheath promotes improved contact force paramenters during pulmonary vein isolation. Heart Rhythm, Vol. 11, No. 5, May Supplement.
  3. Piorkowski C, et al. (2011). Steerable versus non-steerable sheath technology in AF ablation: A prospective, randomized study. Circulation, 4(2), 157–165.
  4. Mansour M. (2014). TOCCASTAR: Preliminary Results of the First Prospective Randomized Study of a Contact Force Sensing Ablation Catheter for the Treatment of Paroxysmal AF. Presented at HRS AF Summit 2014. San Francisco, California.
  5. Hutchinson M, et al. (2013). Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm, 10(3), 347–353.

MAT-2012363 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
abbott logo

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2023 Abbott. All Rights Reserved.

MAT-1900882 v10.0